Diabetes Type 2 Clinical Trial
Official title:
Efektivitas "CARE Coaching Model" Sebagai Upaya Pemberdayaan Pasien Diabetes Untuk Meningkatkan Status Kesehatan Dan Perilaku Pengendalian Diabetes
NCT number | NCT04289818 |
Other study ID # | PS002 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 1, 2018 |
Est. completion date | March 31, 2020 |
Verified date | November 2022 |
Source | Indonesia University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In Indonesia and others countries, only 30.8% patients with type 2 diabetes mellitus (T2DM) achieved glycemic control with HbA1c <7%. Optimal pharmacological treatment alone does not guarantee an optimal outcome, therefore it should be combined with lifestyle management. Health coaching helps T2DM patients increase self awareness to improve and maintain behavior which play a role in self-management. This study aims to evaluate the impact of health coaching on glycemic control on T2DM patients.
Status | Completed |
Enrollment | 60 |
Est. completion date | March 31, 2020 |
Est. primary completion date | August 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 60 Years |
Eligibility | Inclusion Criteria: - T2DM patients - aged 30-60 years old - HbA1C > 7.5% within the past 3 months - able to write and read. Exclusion Criteria: - Patients with cognitive disease (such as dementia) - having hearing problem or sight problem - unable to live independently on daily basis - having disease that may affect HbA1c result (eg: hemolytic anemia) |
Country | Name | City | State |
---|---|---|---|
Indonesia | Faculty of Medicine, Universitas Indonesia | Jakarta Pusat | DKI Jakarta |
Lead Sponsor | Collaborator |
---|---|
Indonesia University |
Indonesia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from Baseline HbA1c at 3 months | Glycemic Control | 3 month after intervention | |
Primary | Change from Baseline HbA1c at 6 months | Glycemic Control | 6 month after intervention | |
Secondary | Change from Baseline Fasting Plasma Glucose at 3 months | Glycemic Control | 3 month after intervention | |
Secondary | Change from Baseline 2-hours post prandial plasma glucose at 3 months | Glycemic control | 3 months after intervention | |
Secondary | Change from HDL-cholesterol at 3 months | Diabetes mellitus control | 3 months after intervention | |
Secondary | Change from LDL-cholesterol at 3 months | Diabetes mellitus control | 3 months after intervention | |
Secondary | Change from Triglycerides at 3 months | diabetes mellitus control | 3 months after intervention | |
Secondary | Change from Total Cholesterol at 3 months | Diabetes mellitus control | 3 months after intervention | |
Secondary | Change of Body mass index at 3 months | Diabetes mellitus control | 3 month after intervention | |
Secondary | Change calorie intake at 3 months | life style parameter | 3 month after intervention | |
Secondary | International Physical Activity Questionnaire (IPAQ) questionnaire | consist of several question about activities in the whole week. Scoring divided into 3 categories : low, moderate, high. This questionnaire is to describe activities no to divided whether high score means good or bad | baseline, 3 month and 6 months after intervention | |
Secondary | EQ-5D quality of life questionnaire | This questionnaire consist of several question with 5 main outcome mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Subjects will answer the question with fully, half or none. | baseline, 3 month and 6 months after intervention | |
Secondary | Change from Baseline Fasting Plasma Glucose at 6 months | Glycemic Control | 6 month after intervention | |
Secondary | Change from Baseline 2-hours post prandial plasma glucose at 6 months | Glycemic Control | 6 months after intervention | |
Secondary | Change from HDL-cholesterol at 6 months | diabetes mellitus Control | 6 months after intervention | |
Secondary | Change from LDL-cholesterol at 6 months | diabetes mellitus Control | 6 months after intervention | |
Secondary | Change from Triglycerides at 6 months | diabetes mellitus Control | 6 months after intervention | |
Secondary | Change from Total Cholesterol at 6 months | diabetes mellitus Control | 6 months after intervention | |
Secondary | Change from systolic and diastolic blood pressure at 6 months | diabetes mellitus Control | 6 months after intervention | |
Secondary | Change calorie intake at 6 months | life style parameter | 6 months after intervention | |
Secondary | Change of Body mass index at 6 months | diabetes mellitus control | 6 months after intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Active, not recruiting |
NCT04954313 -
Baseline Oral Health Study: UnCoVer the Connections to General Health
|
Phase 4 | |
Not yet recruiting |
NCT06437782 -
Exploration of Health Literacy in Diabetes in Reunion Island and France
|
||
Completed |
NCT01354925 -
Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
|
Phase 4 | |
Completed |
NCT01206725 -
Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction
|
N/A | |
Completed |
NCT00997282 -
A Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 2/Phase 3 | |
Completed |
NCT00637546 -
Gait and Balance of Diabetes Type 2 Patients
|
Phase 2/Phase 3 | |
Completed |
NCT00464880 -
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02057497 -
An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms
|
N/A | |
Active, not recruiting |
NCT05014204 -
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
|
N/A | |
Recruiting |
NCT03662217 -
Personalized Nutrition for Diabetes Type 2
|
N/A | |
Completed |
NCT04276051 -
Cryovagotomy Diabetes Trial
|
N/A | |
Completed |
NCT02569684 -
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
|
N/A | |
Active, not recruiting |
NCT01933529 -
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
|
Phase 2 | |
Terminated |
NCT01722474 -
Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.
|
N/A | |
Completed |
NCT00977262 -
Postprandial Inflammation and Fatty Acids
|
N/A | |
Completed |
NCT00518427 -
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
|
Phase 4 | |
Recruiting |
NCT05378620 -
Project Dulce for Filipino-Americans With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT03834207 -
A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy
|
N/A | |
Active, not recruiting |
NCT05228067 -
Enhancing Brain Health by tDCS in Persons With Overweight and Obesity
|
N/A |